Novel 6,5-Bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches

Key Points

• The primary aim is to develop novel 6,5-bicyclic compounds as agonists for the 5-HT2A receptor to treat various psychiatric disorders.
• Development of 6,5-bicyclic compounds as agonists for 5-HT2A receptor
• Pharmaceutical compositions for treatment
• Processes for preparing these compounds.
• Introduction of new compounds that act as 5-HT2A receptor agonists
• Potential applications in treating depression, anxiety, substance abuse, and headaches.